|
시장보고서
상품코드
2024753
히알루론산 원료 시장 분석 : 용도별, 지역별(2026-2034년)Hyaluronic Acid Raw Material Market Report by Application (Ophthalmology, Orthopedics, Dermatology, Drug Delivery, Medical Device Coating, Surgical Adhesion Prevention, Biomaterials and Implants, Cell and Tissue Preservation), and Region 2026-2034 |
||||||
세계의 히알루론산 원료 시장 규모는 2025년에 79억 달러에 달했습니다. 향후, IMARC Group은 2034년까지 시장 규모가 127억 달러에 이르고, 2026-2034년 CAGR은 5.29%를 나타낼 것으로 예측했습니다.
히알루론산 원료는 이 천연 화합물의 제조에 사용되는 물질을 말합니다. 히알루론산은 눈, 머리카락, 관절, 신경, 연골 및 피부의 세포외 기질에 자연적으로 존재합니다. 또한, 밀 펩톤, 설탕, 특정 박테리아를 발효시켜 합성할 수도 있습니다. 이 성분들은 단백질을 구성하고 피부 내 수분 농도를 조절하여 결합조직의 기능을 지원하고 콜라겐 결합을 촉진하는 데 도움을 줍니다. 히알루론산을 국소적으로 바르면 피부 재생을 돕고 염증을 줄일 수 있습니다. 그 결과, 화장품, 약물 전달 시스템, 의약품, 건강보조식품 제조에 폭넓게 활용되고 있습니다.
히알루론산 원료 시장 동향 :
세계 제약 산업의 괄목할만한 성장은 시장의 밝은 전망을 만드는 주요 요인 중 하나입니다. 히알루론산은 점탄성 물질 및 항유착제로 작용하여 조직의 유착을 방지하는 기계적 장벽으로 안과, 피부과, 정형외과 수술에 널리 사용되고 있습니다. 또한, 미용 목적으로 일반인들의 주름 개선 및 안티에이징 크림과 솔루션에 대한 수요가 증가하면서 시장 성장을 견인하고 있습니다. 또한, 표적 약물 전달 및 재생 의료를 위한 혁신적인 솔루션 개발 등 다양한 기술 발전도 성장을 가속하는 요인으로 작용하고 있습니다. 의료진은 히알루론산 주사를 관절 내 윤활, 염증 감소, 연골과 뼈의 성장을 가속하기 위해 널리 활용하고 있습니다. 소비자의 구매력 향상, 활발한 연구개발(R&D) 활동 등 다른 요인들도 시장 성장을 견인할 것으로 예측됩니다.
본 보고서에서 답변을 얻을 수 있는 주요 질문
- 세계의 히알루론산 원료 시장은 지금까지 어떻게 성장해 왔으며, 향후 몇 년 동안 어떻게 성장할 것인가?
- 코로나19는 세계의 히알루론산 원료 시장에 어떤 영향을 미쳤을까?
- 주요 지역 시장은 어디인가?
- 용도별 시장 현황은?
- 이 산업의 가치사슬에서 각 단계는 어떤 역할을 하는가?
- 이 산업의 주요 촉진요인과 과제는?
- 세계 히알루론산 원료 시장의 구조는 어느 정도이며, 주요 기업은 어느 정도입니까?
- 업계의 경쟁은 어느 정도인가?
목차
제1장 서문
제2장 분석 범위 및 방법
제3장 주요 요약
제4장 서론
제5장 세계의 히알루론산 원료 시장
제6장 시장 구분 : 용도별
제7장 시장 구분 : 지역별
제8장 SWOT 분석
제9장 밸류체인 분석
제10장 Porter's Five Forces 분석
제11장 가격 분석
제12장 경쟁 구도
KTH 26.05.20The global hyaluronic acid raw material market size reached USD 7.9 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 12.7 Billion by 2034, exhibiting a growth rate (CAGR) of 5.29% during 2026-2034.
Hyaluronic acid raw materials are the substances used for the manufacturing of the natural compound. The acid is naturally present in the eyes, hair, joints, nerves, cartilages and extracellular matrix in the skin. It can also be synthesized by fermenting wheat peptones, sugar and certain bacteria. These ingredients aid in supporting the functioning of the connective tissues and promoting collagen binding by building up the proteins and regulating water concentration in the skin. The topical application of the acid can assist in the regeneration of the skin and reduce inflammation. As a result, it finds extensive applications in the manufacturing of cosmetics, drug delivery systems, pharmaceuticals and nutritional supplements.
HYALURONIC ACID RAW MATERIAL MARKET TRENDS:
Significant growth in the pharmaceutical industry across the globe is of the key factors creating a positive outlook for the market. Hyaluronic acid acts as a viscoelastic and anti-surgical adhesion agent, which is widely used in ophthalmic, dermatological and orthopedic procedures as a mechanical barrier for tissue adherence. Moreover, the increasing demand for anti-wrinkle and anti-aging creams and solutions among the masses for cosmetic enhancements is providing a thrust to the market growth. Additionally, various technological advancements, such as the development of innovative solutions for targeted drug delivery and regenerative medicines, are acting as other growth-inducing factors. Healthcare providers are extensively using hyaluronic acid injections to provide lubrication, reduce inflammation and promote cartilage and bone growth in the joint. Other factors, including rising expenditure capacities of the consumers, along with extensive research and development (R&D) activities, are anticipated to drive the market toward growth.
KEY MARKET SEGMENTATION:
Breakup by Application:
- Ophthalmology
- Cataract Surgery
- Aqueous Eye Drop
- Contact Lens
- Orthopedics
- Viscosupplements
- Bone Regeneration
- Dermatology
- Intradermal
- Dermal Filler
- Wound Healing
- Drug Delivery
- Medical Device Coating
- Surgical Adhesion Prevention
- Biomaterials and Implants
- Cell and Tissue Preservation
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
COMPETITIVE LANDSCAPE:
The competitive landscape of the industry has also been examined along with the profiles of the key players being AbbVie Inc., Anika Therapeutics Inc., Contipro a.s., Galderma S.A., LG Chem Ltd., Lifecore Biomedical LLC (Landec Corporation), Sanofi S.A., Seikagaku Corporation, Smith & Nephew plc and Zimmer Biomet.
KEY QUESTIONS ANSWERED IN THIS REPORT
- How has the global hyaluronic acid raw material market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global hyaluronic acid raw material market?
- What are the key regional markets?
- What is the breakup of the market based on the application?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global hyaluronic acid raw material market and who are the key players?
- What is the degree of competition in the industry?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Hyaluronic Acid Raw Material Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Application
- 6.1 Ophthalmology
- 6.1.1 Market Trends
- 6.1.2 Key Segments
- 6.1.2.1 Cataract Surgery
- 6.1.2.2 Aqueous Eye Drop
- 6.1.2.3 Contact Lens
- 6.1.3 Market Forecast
- 6.2 Orthopedics
- 6.2.1 Market Trends
- 6.2.2 Key Segments
- 6.2.2.1 Viscosupplements
- 6.2.2.2 Bone Regeneration
- 6.2.3 Market Forecast
- 6.3 Dermatology
- 6.3.1 Market Trends
- 6.3.2 Key Segments
- 6.3.2.1 Intradermal
- 6.3.2.2 Dermal Filler
- 6.3.2.3 Wound Healing
- 6.3.3 Market Forecast
- 6.4 Drug Delivery
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
- 6.5 Medical Device Coating
- 6.5.1 Market Trends
- 6.5.2 Market Forecast
- 6.6 Surgical Adhesion Prevention
- 6.6.1 Market Trends
- 6.6.2 Market Forecast
- 6.7 Biomaterials and Implants
- 6.7.1 Market Trends
- 6.7.2 Market Forecast
- 6.8 Cell and Tissue Preservation
- 6.8.1 Market Trends
- 6.8.2 Market Forecast
7 Market Breakup by Region
- 7.1 North America
- 7.1.1 United States
- 7.1.1.1 Market Trends
- 7.1.1.2 Market Forecast
- 7.1.2 Canada
- 7.1.2.1 Market Trends
- 7.1.2.2 Market Forecast
- 7.1.1 United States
- 7.2 Asia-Pacific
- 7.2.1 China
- 7.2.1.1 Market Trends
- 7.2.1.2 Market Forecast
- 7.2.2 Japan
- 7.2.2.1 Market Trends
- 7.2.2.2 Market Forecast
- 7.2.3 India
- 7.2.3.1 Market Trends
- 7.2.3.2 Market Forecast
- 7.2.4 South Korea
- 7.2.4.1 Market Trends
- 7.2.4.2 Market Forecast
- 7.2.5 Australia
- 7.2.5.1 Market Trends
- 7.2.5.2 Market Forecast
- 7.2.6 Indonesia
- 7.2.6.1 Market Trends
- 7.2.6.2 Market Forecast
- 7.2.7 Others
- 7.2.7.1 Market Trends
- 7.2.7.2 Market Forecast
- 7.2.1 China
- 7.3 Europe
- 7.3.1 Germany
- 7.3.1.1 Market Trends
- 7.3.1.2 Market Forecast
- 7.3.2 France
- 7.3.2.1 Market Trends
- 7.3.2.2 Market Forecast
- 7.3.3 United Kingdom
- 7.3.3.1 Market Trends
- 7.3.3.2 Market Forecast
- 7.3.4 Italy
- 7.3.4.1 Market Trends
- 7.3.4.2 Market Forecast
- 7.3.5 Spain
- 7.3.5.1 Market Trends
- 7.3.5.2 Market Forecast
- 7.3.6 Russia
- 7.3.6.1 Market Trends
- 7.3.6.2 Market Forecast
- 7.3.7 Others
- 7.3.7.1 Market Trends
- 7.3.7.2 Market Forecast
- 7.3.1 Germany
- 7.4 Latin America
- 7.4.1 Brazil
- 7.4.1.1 Market Trends
- 7.4.1.2 Market Forecast
- 7.4.2 Mexico
- 7.4.2.1 Market Trends
- 7.4.2.2 Market Forecast
- 7.4.3 Others
- 7.4.3.1 Market Trends
- 7.4.3.2 Market Forecast
- 7.4.1 Brazil
- 7.5 Middle East and Africa
- 7.5.1 Market Trends
- 7.5.2 Market Breakup by Country
- 7.5.3 Market Forecast
8 SWOT Analysis
- 8.1 Overview
- 8.2 Strengths
- 8.3 Weaknesses
- 8.4 Opportunities
- 8.5 Threats
9 Value Chain Analysis
10 Porters Five Forces Analysis
- 10.1 Overview
- 10.2 Bargaining Power of Buyers
- 10.3 Bargaining Power of Suppliers
- 10.4 Degree of Competition
- 10.5 Threat of New Entrants
- 10.6 Threat of Substitutes
11 Price Analysis
12 Competitive Landscape
- 12.1 Market Structure
- 12.2 Key Players
- 12.3 Profiles of Key Players
- 12.3.1 AbbVie Inc.
- 12.3.1.1 Company Overview
- 12.3.1.2 Product Portfolio
- 12.3.1.3 Financials
- 12.3.1.4 SWOT Analysis
- 12.3.2 Anika Therapeutics Inc.
- 12.3.2.1 Company Overview
- 12.3.2.2 Product Portfolio
- 12.3.2.3 Financials
- 12.3.2.4 SWOT Analysis
- 12.3.3 Contipro a.s.
- 12.3.3.1 Company Overview
- 12.3.3.2 Product Portfolio
- 12.3.4 Galderma S.A.
- 12.3.4.1 Company Overview
- 12.3.4.2 Product Portfolio
- 12.3.5 LG Chem Ltd.
- 12.3.5.1 Company Overview
- 12.3.5.2 Product Portfolio
- 12.3.5.3 Financials
- 12.3.5.4 SWOT Analysis
- 12.3.6 Lifecore Biomedical LLC (Landec Corporation)
- 12.3.6.1 Company Overview
- 12.3.6.2 Product Portfolio
- 12.3.7 Sanofi S.A.
- 12.3.7.1 Company Overview
- 12.3.7.2 Product Portfolio
- 12.3.7.3 Financials
- 12.3.7.4 SWOT Analysis
- 12.3.8 Seikagaku Corporation
- 12.3.8.1 Company Overview
- 12.3.8.2 Product Portfolio
- 12.3.8.3 Financials
- 12.3.9 Smith & Nephew plc
- 12.3.9.1 Company Overview
- 12.3.9.2 Product Portfolio
- 12.3.9.3 Financials
- 12.3.9.4 SWOT Analysis
- 12.3.10 Zimmer Biomet
- 12.3.10.1 Company Overview
- 12.3.10.2 Product Portfolio
- 12.3.10.3 Financials
- 12.3.1 AbbVie Inc.
